Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
Want to monitor ASB-PE?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ASB-PENo company information available
No data available